Intravascular Catheterization Market Report 2026

Intravascular Catheterization Market Overview

• Intravascular Catheterization market size has reached to $13.54 billion in 2025 • Expected to grow to $18.83 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Increase In Cardiovascular Disorders Driving The Growth Of The Market Due To Rising Obesity And Associated Risk Factors • Market Trend: AI-Powered Intravascular Ultrasound (IVUs) Systems Revolutionizing Vascular Imaging • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Intravascular Catheterization Market?

Intravascular catheterization is the insertion of a catheter into a blood vessel to provide access for administering medications or fluids or for monitoring purposes. It is commonly used in medical settings to deliver treatments directly into the bloodstream or to measure hemodynamic parameters. The main types of intravascular catheterization are centrally inserted catheters, peripherally inserted central catheters (PICC), peripheral catheters, and dialysis catheters. Centrally inserted catheters are long-term access devices placed into large central veins such as the subclavian or jugular. It includes various materials such as polyurethane, silicone, polyvinyl chloride (PVC), and others used for various procedures, including elective procedures, emergency procedures, interventional radiology, and cardiac procedures. It finds applications in oncology, cardiology, pediatrics, and infection control, catering to various end users, such as hospitals, ambulatory surgical centers (ASCs), home healthcare, and research laboratories.

What Is The Intravascular Catheterization Market Growth Forecast?

The intravascular catheterization market size is expected to see strong growth in the next few years. It will grow to $18.83 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular access, rising focus on reducing catheter-related infections, expansion of outpatient and home-based care, technological advancements in catheter design, growing use of smart monitoring catheters. Major trends in the forecast period include increasing use of advanced central and peripheral catheters, rising demand for infection-resistant materials, growing adoption of long-term vascular access solutions, expansion of image-guided catheter placement, enhanced focus on patient safety and comfort.

Global Intravascular Catheterization Market Segmentation

1) By Type: Centrally Inserted Catheters, Peripherally Inserted Central Catheters (PICC), Peripheral Catheters, Dialysis Catheters 2) By Material: Polyurethane, Silicone, Polyvinyl Chloride (Pvc), Other Materials 3) By Procedures: Elective Procedures, Emergency Procedures, Interventional Radiology, Cardiac Procedures 4) By Application: Oncology, Cardiology, Pediatrics, Infection Control 5) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Home Healthcare Subsegments: 1) By Centrally Inserted Catheters: Non-Tunneled Central Venous Catheters, Tunneled Central Venous Catheters, Implantable Ports 2) By Peripherally Inserted Central Catheters (PICC): Single Lumen PICC, Double Lumen PICC, Triple Lumen PICC 3) By Peripheral Catheters: Short Peripheral Intravenous Catheters, Midline Catheters, Winged Infusion Sets 4) By Dialysis Catheters: Temporary Dialysis Catheters, Tunneled Dialysis Catheters, Non-Tunneled Dialysis Catheters

What Is The Driver Of The Intravascular Catheterization Market?

The increasing incidence of cardiovascular disorders is expected to propel the growth of the intravascular catheterization market going forward. Cardiovascular disorders refer to a range of conditions that affect the heart and blood vessels, such as heart disease, stroke, and high blood pressure. The increasing incidence of cardiovascular disorders is largely due to the rising rates of obesity, which contribute to risk factors such as high blood pressure and diabetes, both of which increase the likelihood of heart disease. Intravascular catheterization is useful for cardiovascular disorders, as it allows for minimally invasive procedures to diagnose and treat conditions such as coronary artery disease, perform angioplasty, and place stents to improve blood flow. For instance, in October 2025, according to Centers for Disease Control and Prevention, a US-based government agency, reported that, in 2023, 919,032 people died from cardiovascular disease. That's the equivalent of 1 in every 3 deaths. Further, every year about 805,000 people in the United States have a heart attack. Therefore, the increasing incidence of cardiovascular disorders is driving the growth of the intravascular catheterization industry.

Key Players In The Global Intravascular Catheterization Market

Major companies operating in the intravascular catheterization market are Cardinal Health Inc., Johnson & Johnson (C. R. Bard), Medtronic plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Teleflex Incorporated, Cook Medical LLC, ICU Medical Inc., Smiths Medical, Merit Medical Systems Inc., Vygon SA, AngioDynamics Inc., ACIST Medical Systems Inc., Shanghai Kindly Enterprise Development Group Co. Ltd., Fresenius Medical Care AG & Co. KGaA, Medline Industries Inc., Argon Medical Devices Inc., Rex Medical LP, Galt Medical Corp., Poly Medicure Ltd.

Global Intravascular Catheterization Market Trends and Insights

Major companies operating in the intravascular catheterization market are focusing on developing technologically advanced solutions, such as artificial intelligence (AI)-powered intravascular ultrasound (IVUS) systems, to enhance imaging precision and streamline clinical workflows. AI-powered intravascular ultrasound (IVUS) systems refer to advanced medical imaging devices that combine traditional intravascular ultrasound (IVUS) technology with artificial intelligence (AI) algorithms to improve the accuracy, efficiency, and interpretability of imaging during cardiovascular procedures. For instance, in October 2023, Evident Vascular Inc., a US-based medical technology company, launched an AI-enabled intravascular ultrasound (IVUS) platform designed to capture high-precision images from inside blood vessels, primarily to assess vascular disease and guide interventional treatments. This next-generation, catheter-based ultrasound technology leverages artificial intelligence to enhance image quality, improve interpretation, and streamline workflow for clinicians, with an initial focus on peripheral vascular interventions and plans to expand into coronary applications.

What Are Latest Mergers And Acquisitions In The Intravascular Catheterization Market?

In April 2025, Boston Scientific Corporation, a US-based provider of minimally invasive cardiovascular devices, acquired Bolt Medical for $443 million. With this acquisition, Boston Scientific aims to expand its cardiovascular portfolio with a complementary, next-generation intravascular lithotripsy (IVL) technology, enabling the company to better address complex calcified arterial disease and strengthen its position in minimally invasive interventional cardiology therapies. Bolt Medical is a US-based medical technology company focusing on the design and development of innovative laser-based intravascular lithotripsy (IVL) catheters.

Regional Outlook

North America was the largest region in the intravascular catheterization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Intravascular Catheterization Market?

The intravascular catheterization market includes revenues earned by entities by providing services such as coronary angiography, percutaneous coronary intervention, dialysis catheter insertion, and neurological applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The intravascular catheterization market also consists of sales of vascular access catheters, guiding catheters, introducer sheaths, hemodialysis catheters, and balloon catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.